step 2 semaglutide 2·4 mg once a week in adults with overweight or obesity, and type diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Once-weekly semaglutide 7·2 mg in

In elective TJA, where tolerance for biologic uncertainty is low, the most defensible approach remains risk minimization

Lavertu, E

The changing epidemiology of adult liver transplantation in the United States in 20132022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease

However, current knowledge of the hygroscopicity of sub-10 nm organic nanoparticles and their concentration-dependent thermodynamic properties (e.g., water activity) in the highly supersaturated concentration range is scarcely available

GHRH (Growth Hormone Releasing Hormones) such as CJC-1295 and the tesamorelin activate the GHRH-R receptor of the pituitary gland and initiate the pulsatile release of GH

Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Sillje HH: Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A